Posted on Apr 25, 2011 By Jackson Allen Williams, LLP
April 25, 2011 - Two articles published in British Medical Journal over the weekend confirm previous studies that show an increased risk of venous thromboembolic events including stroke , pulmonary ...
Continue reading "Two New Articles Confirm Increased Risk of Venous Thromboembolism in Yaz & Yasmin Users" »
Posted on Apr 19, 2011 By Jackson Allen Williams, LLP
On April 18, 2011 the Canadian Medical Association Journal published an article that reports a statistically significant increase in the risk of gallbladder diseases associated with dropserinone, ...
Continue reading "Yaz/Yasmin May Put Women at Increased Risk for Gallbladder Disease" »
Posted on Sep 22, 2010 By Jennifer Williams
The FDA recently approved Watson Laboratories, Inc.'s female oral contraceptive pill marketed as Zarah. Zarah is the generic equivalent to Yasmin, the birth control pill marketed by Bayer. Bayer had ...
Continue reading "New Yasmin Generic Approved by FDA" »